BY OUR PLATFORMS
BY THERAPEUTIC AREA
BY RESEARCH STAGE
26 August 2021 - 27 August 2021
ZeClinics will contribute to the ACTRA Annual Scientific Meeting with an oral presentation of our Co-founder and CDD Javier Terriente
08 July 2021
07 July 2021 - 09 July 2021
ZeClinincs will attend the meeting to present its work on standardization of developmental neurotoxicity assessment.
28 June 2021
16 June 2021 - 22 June 2021
ZeClinics is presenting in IZFC 2021.
10 June 2021 - 18 June 2021
ZeClinics is participating in the BIO Digital 2021.
25 May 2021
We are happy to announce ZeClinics participation in e-ECE 2021.
17 May 2021
ZeCardio Therapeutics busca cinco millones para acelerar en investigación cardiovascular
04 May 2021
ZeClinics es una de las 3 startups españolas seleccionadas en el programa Bridgehead Global, que permitirá la internalización de sus proyectos a nivel mundial.
03 May 2021 - 06 May 2021
We are pleased to announce ZeClinics involvement in SETAC Europe 2021.
12 March 2021 - 26 March 2021
ZeClinics is participating as exhibitor at the largest Toxicology event
01 March 2021
25 February 2021
Cáncer, enfermedades infecciosas, genéticas, alimentación sostenible para todos, plantas resistentes a la sequía, bioeconomía o alimentación funcional. Estas son algunas de las aplicaciones de CRISPR
17 February 2021
ZeClinics and ERS Genomics sign CRISPR/Cas9 license agreement.
16 February 2021
ERS Genomics and ZeClinics sign CRISPR/Cas9 license agreement
ZeClinics gains access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
Please leave your details in the form below.